osteoporosis

The evolving role of real-world evidence in secondary fracture prevention

Andrea_Puletto — Fri, 11 Apr 2025 09:52:02 +0000

The evolving role of real-world evidence in secondary fracture prevention

Steve Turley, Bone Health Developed Brands

Andrea_Puletto Fri 11/04/2025 - 11:52

In osteoporosis research and clinical practice, the value of real-world evidence (RWE) is increasingly acknowledged; but much of its potential remains untapped. By analyzing real-world treatment patterns, RWE provides deeper insights into the effectiveness of osteoporosis treatments. Unlike clinical trials, which operate under controlled conditions, RWE captures the realities of routine clinical practice.

Worldwide, osteoporosis is estimated to cause fractures in a staggering one in three women over the age of 50, and in women over 45 years of age, osteoporosis accounts for more days in hospital than many other diseases, including diabetes, myocardial infarction and breast cancer.

With 71% of patients who sustain fractures related to osteoporosis remaining undiagnosed and untreated, data around treatment journeys is essential to help close the gap. A comprehensive picture of how patients experience care, manage their condition and navigate healthcare systems is lacking.

Highlighting the impact of RWE at WCO-IOF-ESCEO

At the 25th WCO-IOF-ESCEO Congress in Rome, Italy, ��ֳ�, its partner, Amgen and investigators from supported investigator-initiated studies, are presenting eight abstracts, further building the body of RWE that can be used to elevate care for those at high risk of fracture.

These data will allow us to better characterize patients at high fracture risk and get a clearer picture of their treatment journeys. These insights are guiding how we support clinicians to prioritize early, targeted interventions for patients most at risk of fracture.

At ��ֳ�, it is our mission that everyone with osteoporosis at very high fracture risk (VHFR) receives the appropriate investigation and intervention that they need, with the aim to create a world free of fragility fractures.

We are fully embracing the opportunity that RWE brings, generating data that deepens understanding of VHFR care and informs better treatment decisions. By working closely with healthcare professionals to leverage real-world insights, we can ensure that fewer patients at very high fracture risk fall through the cracks.

solutions

Comment:

Posted by yliana Muñoz Bravo , 15 April 2025

Excelente y beatyfull

121 Likes

Closing the gap in osteoporosis: It’s make or break for post-fracture care

Andrea_Puletto — Wed, 10 Apr 2024 07:29:04 +0000

Closing the gap in osteoporosis: It’s make or break for post-fracture care

Nico Reynders, Bone Health Mission

Andrea_Puletto Wed 10/04/2024 - 09:29

We can’t escape the facts. Around the world, the treatment gap in osteoporosis continues to be as pervasive as it is affecting; in an international survey last year, the International Osteoporosis Foundation (IOF) revealed that almost one in two women after the age of 50 and over experienced a fracture. Paradoxically, bone health – and the chance to identify and treat the underlying osteoporosis – was neglected during medical check-ups. The ramifications of this missed opportunity are huge.

Why does this matter? The impact on daily life for women with osteoporosis should not be underestimated, with fractures marked by excruciating pain, immobilization, and prolonged hospitalization, robbing them of their independence. This can have a significant impact on their well-being, leaving women feeling anxious and isolated. The lack of appropriate intervention at this crucial trigger point of the patient journey places a staggering burden on healthcare systems, with the cost of fractures in the EU anticipated to hit 77 billion EUR by 2050.

In the past year, we have made great progress in elevating secondary fracture prevention on government agendas – for example, the success in Japan following its reimbursement scheme for Fracture Liaison Services (FLSs) and last year’s announcement of a government-funded osteoporosis knowledge center in Stockholm, Sweden – however, global efforts to tackle the treatment gap fall short of what is truly necessary. And, with the global population aging at a phenomenal rate, it is rapidly becoming a challenge we can no longer afford to ignore.

Closing the gaps in osteoporosis

As global leaders of the bone health community gather in London this week for the World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases, we have a unique opportunity to confront some of the barriers that prevent us from the delivery of optimal patient care:

Knowledge gap: IOF’s survey highlighted a disconnect between the occurrence of fractures amongst women at high-risk of osteoporosis and the decision by healthcare professionals to perform a diagnostic scan. And, as described by Kassim Javaid in the latest episode of the ��ֳ� podcast, Fragility Fractures in Focus, the lack of a recognized ‘bone specialism’ has resulted in a lack of clarity around which practitioners ‘own’ this area of medicine, and consequently, how it should be delivered effectively. How can we therefore equip ALL healthcare practitioners with the knowledge and the tools they need to ensure everyone with osteoporosis receives appropriate investigation and intervention after experiencing a fracture?

Fragmented pathways: In most healthcare systems, patients who experience a fracture are often faced with disjointed pathways that are unable to deliver the necessary assessment for osteoporosis, once again, leading to missed opportunities for timely diagnosis, initiation of appropriate treatments and implementation of preventive measures to reduce the risk of subsequent fractures.

Patient education and empowerment: Empowering patients with accurate information, clear guidance in treatment regimens and supporting resources can enable them to make informed decisions and take an active role in their care by having effective conversations with their doctors.

Post-fracture care – make or break?

Fortunately, a means to bridge these gaps already exists. Coordinated, multidisciplinary services such as FLSs enable rapid referral, facilitate early intervention and improve secondary fracture prevention. These services provide a seamless pathway post-fracture by systematically identifying patients, assessing their fall and fracture risk, and carefully evaluating the most effective intervention, placing the individual’s needs at the center of care. FLSs have been shown to be both clinically and cost-effective , and are described as the single most important step in directly improving patient care and reducing spiraling fracture-related healthcare costs worldwide.

But having a solution is only half the challenge. Global implementation of coordinated post-fracture services is dependent on the close collaboration between policymakers, payers, healthcare professionals and the pharmaceutical industry, and a unified commitment to elevate secondary fracture prevention as a healthcare priority.

We are proud to work closely with partners such as the Fragility Fracture Network and IOF, which look to make this vision a reality – IOF’s Capture the Fracture® program recently celebrated a tremendous milestone of 900 registered FLSs worldwide, doubling the number of services since 2019. To support those looking to start a new FLS or improve the performance of an existing service, we and our partners at Amgen established the FLS Academy and Network (FAN), an educational program led by a Scientific Steering Committee of international experts. FAN offers healthcare professionals practical resources, expert guidance and access to knowledge-sharing events designed to help overcome the challenges faced by those on the ground.

The evidence is in front of us – we already have the tools at our disposal to close the treatment gap in osteoporosis. Through a multidisciplinary approach and the prioritization of secondary fracture prevention on a national, regional, and global level, we can create a world free of fragility fractures.

To hear more on how we can close the treatment gap in osteoporosis, listen to the latest episode of Fragility in Fractures Focus here https://open.spotify.com/episode/7DZrvyPpQfQktd3OVFZj5y?si=2dee74488a4849b7.

innovation

bone osteoporosis International Osteoporosis Foundation IOF Fragility Fractures in Focus WCO-IOF-ESCEO

341 Likes

��ֳ� rounds off Fragility Fractures in Focus podcast series with two bone health congresses – FFN & ASBMR

Vanco Vlastimil (��ֳ� S.A.) — Mon, 02 Oct 2023 10:08:57 +0000

��ֳ� rounds off Fragility Fractures in Focus podcast series with two bone health congresses – FFN & ASBMR

Nico Reynders, Bone Mission

Vanco Vlastimi… Mon 02/10/2023 - 12:08

��ֳ� is rounding off the 2023 Fragility Fractures in Focus podcast series with the two bone health congresses. The episodes will be released in conjunction with the 11th Fragility Fracture Network (FFN) Global Congress 2023 in Oslo (3rd-6th October) and the 2023 American Society for Bone and Mineral Research (ASBMR) Annual Meeting in Vancouver (13th-16th October).

Hosted by Cesar Libanati, ��ֳ�’s Head of Medical Affairs and Medical Strategy, Bone, Fragility Fractures in Focus is based on the P4 Health Spectrum framework, which looks to shift focus away from disease to the promotion of a state of wellness, defined as a state of optimal health. The four Ps – predictive, preventive, personalized and participatory – are intrinsically patient-centric, allowing each episode to explore how the model can create value for people living with osteoporosis.

This year, the 11th FFN Global Congress’ theme is ‘enlightening fragility fracture care’. We believe that patients who play an active role in the management of their osteoporosis can have a transformational impact on outcomes. The third podcast – entitled Power to the Patient – unpacks how this works practically in the clinical setting, focusing on the ‘Participatory’ component of the P4 framework. Dr Zoe Paskins, Consultant Rheumatologist at Keele University, joins us to discuss how the right tools and resources can support patients to make informed decisions along the care pathway.

The ASBMR Annual Meeting is the world’s largest and most diverse bone congress, bringing together experts in the fields of bone, mineral and musculoskeletal health to explore the latest advancements in disease management. In the fourth and final episode of Fragility Fractures in Focus – entitled This Time, It’s Personal – we are joined by Dr Kenneth Poole, Professor of Metabolic Bone Disease and Consultant Rheumatologist at the NIHR Cambridge Biomedical Research Centre, who deep dives into the topic of personalization and how the latest digital tools and AI can enhance post-fracture care.

Worldwide, osteoporosis causes more than 8.9 million fractures annually, resulting in an osteoporosis fracture every 3 seconds. However, osteoporosis is alarmingly overlooked – up to 80% of people who have suffered at least one fragility fracture are left undiagnosed or untreated. Adopting a patient-centered approach – one which harnesses the power of digital innovation – can help us to close this significant treatment gap for patients.

Listen NOW to the Fragility Fractures in Focus podcast to find out more! (For healthcare professionals only).

about ucb

Bone Health Fragility Fractures in Focus FFN ASBMR osteoporosis

430 Likes

Transforming rheumatology

Vanco Vlastimil (��ֳ� S.A.) — Fri, 12 May 2023 07:00:00 +0000

Transforming rheumatology

Athanasia Gkiouleka, Rheumatology Mission

Vanco Vlastimi… Fri 12/05/2023 - 09:00

At ��ֳ�, we embrace the possibility to transform the lives of people living with psoriatic arthritis (PsA), axial spondyloarthritis (axSpA), systemic lupus erythematosus (SLE) and osteoporosis.

Despite the progress made in recent years, there remains a significant unmet need for people living with rheumatic diseases. We are hopeful, however, that the solid foundation established in partnership with the scientific community provides the opportunity to elevate care for people living with rheumatic diseases, allowing them to live as free as possible from the challenges and uncertainty caused by their disease.

Building on more than 30 years of research, we are now exploring approaches to move from symptomatic treatment to disease modification and cure. Our evolving rheumatology portfolio gives us the potential to deliver and expand value for numerous patient populations, including those living with axSpA, PsA and osteoporosis.

Through our unique mix of expertise, innovation and ambition, we aim to pioneer and accelerate scientific advancements which make a meaningful difference to people living with rheumatic diseases. Have a look at the infographic below to learn how ��ֳ� is aiming to transform rheumatology.

Inspired by patients, driven by science, we are ��ֳ�.

To learn more about ��ֳ�’s commitment to people living with rheumatic diseases, visit www.ucb.com/disease-areas

about ucb

rheumatology psoriatic arthritis axial spondyloarthritis Systemic lupus erythematosus osteoporosis

440 Likes

��ֳ� launches new podcast series in time for ECTS 2023: Fragility Fracture in Focus

Vanco Vlastimil (��ֳ� S.A.) — Wed, 12 Apr 2023 10:10:38 +0000

��ֳ� launches new podcast series in time for ECTS 2023: Fragility Fracture in Focus

Adriaan Snauwaert, Global Communications & Company Reputation

Vanco Vlastimi… Wed 12/04/2023 - 12:10

��ֳ� is marking the start of bone health congress season with a brand new and exciting podcast series, “Fragility Fractures in Focus”.

Launching in time to coincide with the start of the European Calcified Tissue Society (ECTS) congress in Liverpool, UK (April 15-18) the first episode features special guests, Prof Bente Langdahl, Aarhus University in Denmark and Prof Richard Eastell, Sheffield University, UK.

The series will be hosted by ��ֳ�’s Head of Medical External Affairs, Cesar Libanati and provides guests and listeners alike, to dive deeper into the most pressing issues impacting clinical practice today. Each episode focuses one of the ‘Ps’ from the P4 Health Spectrum (predictive, preventive, personalized, and participatory) – an increasingly recognized cornerstone of proactive modern medicine – which looks to shift focus away from disease to the promotion of a state of wellness, defined as a state of optimal health.

The theme for the first episode will be “predictive”, focusing on:

Different biomarkers as predictors of optimal protection and fracture prevention
Assessing the role of 'optimized treatment strategies' and their practical application in clinical practice

“The Fragility Fractures in Focus podcast series underscores ��ֳ�’s continued commitment to creating value for patients and the scientific community”, explaines Nico Reynders, Head of Bone Mission. “��ֳ� is proud to showcase its continuous work at ECTS, which aims to improve treatment outcomes for people living with osteoporosis, close the treatment gap and, ultimately, reduce the risk of fragility fractures.”

Curious? You can listen to the podcast here (for healthcare professionals only):

Stay up to date with the latest ��ֳ� news at ECTS 2023 through our social media channels (Twitter, LinkedIn) and get involved using #ECTS2023.

about ucb

fragility fracture osteoporosis ECTS

366 Likes

World Osteoporosis Day 2022: Question Fractures More

Vanco Vlastimil (��ֳ� S.A.) — Mon, 17 Oct 2022 08:22:05 +0000

World Osteoporosis Day 2022: Question Fractures More

Adriaan Snauwaert, Global Communications & Company Reputation

Vanco Vlastimi… Mon 17/10/2022 - 10:22

Together, let’s aim to create a world free from fragility fractures.

World Osteoporosis Day (WOD) takes place every year on October 20 – it marks a year-long campaign dedicated to raising global awareness of the prevention, diagnosis and treatment of osteoporosis, a condition in which the quality and density of bone is reduced, making bones weak, fragile and more likely to break.

Worldwide, osteoporosis causes a fragility fracture every 3 seconds, resulting in more than 8.9 million fragility fractures every year. Despite this, most individuals in high-risk groups and their caregivers, friends and family – and crucially, healthcare professionals – do not question the underlying cause behind fragility fractures. As a result, osteoporosis is often overlooked – up to 80% of people who have suffered at least one fragility fracture are neither identified nor treated. Below, Professor Eugene McCloskey, Honorary Consultant and Professor in Adult Bone Disease at the University of Sheffield, shares his insights into how osteoporosis is identified and diagnosed.

Osteoporosis can have a crucial impact on a person’s life, as fragility fractures have the potential to impose a significant burden on quality of life, often making everyday activities such as eating, dressing, shopping or driving difficult.

To mark this year’s World Osteoporosis Day on 20 October, ��ֳ� launched QUESTION FRACTURES MORE – a creative campaign designed to raise awareness of osteoporosis as the underlying cause of fragility fractures, and to inspire action amongst those at high-risk and their loved ones to help prevent future fractures.

The campaign features a range of exciting, educational content across ��ֳ�.com and ��ֳ� social media channels, encouraging audiences to assess everyday scenarios that can lead to fragility fractures, and identify osteoporosis as the underlying cause. In doing so, the campaign reinforces fragility fractures as a warning sign of the disease and acts as a call to action to prevent secondary fractures.

Additionally, ��ֳ� is proud to continue its longstanding partnership with the International Osteoporosis Foundation (IOF), who organises WOD every year. ��ֳ� will be supporting IOF’s multiple projects to collaboratively establish osteoporosis as a national health priority across the globe.

As innovators in bone health, it is our goal to help educate friends, family, colleagues – and importantly, ourselves – in the significance of fragility fractures.

By strengthening the connection between fragility fractures and osteoporosis, we are taking another important step towards creating a world free from fragility fractures!

Visit our Osteoporosis page to find out more.

#IsItOP

about ucb

World Osteoporosis Day osteoporosis bone fragility fractures

223 Likes

��ֳ� at ECTS 2022: Highlighting solutions to meet the needs of people living with osteoporosis

Vandenbruaene Nathalie — Fri, 06 May 2022 08:54:29 +0000

��ֳ� at ECTS 2022: Highlighting solutions to meet the needs of people living with osteoporosis

Adriaan Snauwaert, Global Communications & Company Reputation

Vandenbruaene … Fri 06/05/2022 - 10:54

The upcoming digital and in-person European Calcified Tissue Society (ECTS) congress in Helsinki, taking place from the 7th – 10th May 2022, will be bringing together leading members of the musculoskeletal field to highlight and discuss the latest opportunities and challenges in this space. We look forward to take part in this congress, as we will be highlighting data published earlier this year, that paves the way to reducing fracture risk and improving the outcomes for people living with osteoporosis.

For this year’s ECTS, 5 abstracts that are supported by ��ֳ� were accepted, these include 2 plenary oral presentations, 2 oral presentations and 1 poster, focusing on a range of topics such as osteoporosis treatment, fracture risk and identified vertebral fractures. ��ֳ� will also be hosting an industrial symposium on the 8th May with leading experts Dr Ralph Müller, Dr Richard Abel and Dr Roland Chapurlat, who will be discussing the mechanisms by which bone-forming therapies impact bone strength.

Osteoporosis, which affects approximately 200 million people globally, is a condition characterized by fragility fractures due to compromised bone strength.1 ��ֳ� is proud to showcase its continuous work at ECTS and continuously works towards improving treatment outcomes for people living with osteoporosis, close the treatment gap and reduce the risk of fragility fractures.

Stay up to date with the latest ��ֳ� news at ECTS 2022 through our social media channels (Twitter, LinkedIn) and get involved using #ECTS2022.

about ucb

ECTS European Calcified Tissue Society Congress osteoporosis fractures

436 Likes

Adoption of innovation is essential to the future of osteoporosis care

eCMSadmin — Fri, 11 Sep 2020 00:00:00 +0000

Adoption of innovation is essential to the future of osteoporosis care

Scott Fleming, Global Communications & Company Reputation

eCMSadmin Fri 11/09/2020 - 02:00

This year’s American Society of Bone Mineral Research (ASBMR) annual congress takes place on 11-15 September. Despite taking the virtual stage, ASBMR remains to be a prominent centre point for the latest clinical and scientific developments in bone health. That is why we are excited to be taking part in this year’s congress, connecting with the osteoporosis community and hearing about the latest advances in bone health from around the world.

We believe that ongoing research is essential to keep the field moving toward optimal osteoporosis management and fracture prevention, but how much progress has been made with recent innovation in osteoporosis? A few years ago, we saw a welcome shift in the way osteoporosis is managed with the implementation of the Fracture Liaison Service (FLS). Best practices like the FLS have already undergone rigorous improvement over time, and their benefit is already widely acknowledged. More uptake of these services will provide solutions to the disconnect between patient and healthcare professional.

In addition to best practice processes like an FLS program, patients and physicians alike could benefit from a more individualized approach to treating and monitoring osteoporosis and fracture risk. In recent years, working groups and expert consensuses have expressed the potential benefit of a treat-to-target strategy to reduce the risk of fragility fractures. We can learn from other therapeutic areas which have benefited from a disease-specific treat-to-target approach to individualise the treatment of each patient based on their probability of reaching a treatment goal. These groups have commented that progress toward reaching the patient’s goal would include periodic and systematic assessment.

For physicians and their patients with osteoporosis, this could open up a new and refined approach to use existing therapies. Ideally, using biomarkers that are reliable, easily measured and cost effective and setting targets that are realistic, adaptable and have evidence of the benefits, could result in a strategy to help reduce fragility fracture risk while providing important near-term feedback to patients that their treatment is making a difference.

ASBMR will see the sharing of the latest clinical and scientific developments in bone health but we need health systems and policy makers involved in bringing these innovations to life, ensuring osteoporosis is no longer overlooked and under prioritised. Tried and tested services such as the FLS should be implemented as widely as possible, new treatment approaches should be considered and corporations and healthcare systems should invest in treatments, processes and devices, all with patients’ needs at the forefront to make innovation happen within osteoporosis.

about ucb

ASBMR osteoporosis FLS bone

812 Likes

Osteoporosis care: bringing innovation to those that will benefit the most

eCMSadmin — Mon, 06 Apr 2020 00:00:00 +0000

Osteoporosis care: bringing innovation to those that will benefit the most

Scott Fleming, Global Communications & Company Reputation

eCMSadmin Mon 06/04/2020 - 02:00

Innovation drives our search for new therapies that bring value to patients. However, for innovative treatments to have maximum impact on patient care, they must be readily available to those who need them most.

In the third of a series of thought leader articles by ��ֳ� personnel, in partnership with the Health Europa journal, we look at the adoption of innovation in osteoporosis care and management. Our goal is to ensure that the needs of the growing number of people at risk of fractures are highlighted.

Consider the fact: almost half of patients who suffer an osteoporotic hip fracture have experienced a previous osteoporotic fracture, but most of these patients did not receive treatment that could have reduced their risk of hip fracture. This represents a significant missed opportunity to prevent painful broken bones that can impact quality of life.

Innovation should focus on early diagnosis and prevention of future fractures; too many patients remain undiagnosed and untreated today, disconnected from the healthcare professionals who can help manage their disease, meaning they remain at risk of fractures that can lead to disability, loss of quality of life, and premature death.

The risk of fragility fractures rises with age, making osteoporosis care a priority for the future. As populations age, it will become increasingly important to ensure that older people have access to the services and care they need to stay healthy.

Some healthcare professionals are concerned by the level of access to innovation in osteoporosis. Research conducted by ��ֳ�, showed that over a quarter (28%) of bone specialists rated the level of innovation in osteoporosis as below average or poor and, they agreed that health systems are not doing enough to support. If we continue on this path, millions of people risk missing out on an acceptable quality of later life as they age. Ageing is inevitable, but how we age is not.

Of course, innovation is not all about new therapies or technologies. Innovative models of service delivery play a vital role in fracture prevention. A few years ago, we saw a welcome shift in the way osteoporosis is managed with the implementation of the Fracture Liaison Service (FLS). Best practices like the FLS have already undergone rigorous improvement over time, and their benefit is already widely acknowledged. More uptake of these services will provide solutions to the disconnect between patient and healthcare professional.

In addition to best practice processes like an FLS program, patients and physicians alike could benefit from a more individualized approach to treating and monitoring osteoporosis and fracture risk. The availability of reliable biomarkers also promises to make fracture prevention more effective and personal.

Looking ahead, using artificial intelligence (AI) algorithms to analyse bone scans could help to identify patients susceptible to future fractures and lead to more effective clinical intervention, ultimately driving towards reducing the co-morbidities associated with osteoporosis.

For our part, ��ֳ� is working to advance osteoporosis management and fracture prevention. We will continue to strive to deliver value to patients by developing new therapies and embracing the latest technologies. It is vital that patients have access to these new tools if we are to tackle healthy ageing together.

solutions

patient value osteoporosis innovation Health Europa fracture FLS

791 Likes

osteoporosis

The evolving role of real-world evidence in secondary fracture prevention

Leave a Comment

Closing the gap in osteoporosis: It’s make or break for post-fracture care

Leave a Comment

��ֳ� rounds off Fragility Fractures in Focus podcast series with two bone health congresses – FFN & ASBMR

Leave a Comment

Transforming rheumatology

Leave a Comment

��ֳ� launches new podcast series in time for ECTS 2023: Fragility Fracture in Focus

Leave a Comment

World Osteoporosis Day 2022: Question Fractures More

Together, let’s aim to create a world free from fragility fractures.

Leave a Comment

��ֳ� at ECTS 2022: Highlighting solutions to meet the needs of people living with osteoporosis

Leave a Comment

Adoption of innovation is essential to the future of osteoporosis care

Leave a Comment

Osteoporosis care: bringing innovation to those that will benefit the most

Leave a Comment

osteoporosis

The evolving role of real-world evidence in secondary fracture prevention

Leave a Comment

Closing the gap in osteoporosis: It’s make or break for post-fracture care

Leave a Comment

������ֳ� rounds off Fragility Fractures in Focus podcast series with two bone health congresses – FFN & ASBMR

Leave a Comment

Transforming rheumatology

Leave a Comment

������ֳ� launches new podcast series in time for ECTS 2023: Fragility Fracture in Focus

Leave a Comment

World Osteoporosis Day 2022: Question Fractures More

Together, let’s aim to create a world free from fragility fractures.

Leave a Comment

������ֳ� at ECTS 2022: Highlighting solutions to meet the needs of people living with osteoporosis

Leave a Comment

Adoption of innovation is essential to the future of osteoporosis care

Leave a Comment

Osteoporosis care: bringing innovation to those that will benefit the most

Leave a Comment

��ֳ� rounds off Fragility Fractures in Focus podcast series with two bone health congresses – FFN & ASBMR

��ֳ� launches new podcast series in time for ECTS 2023: Fragility Fracture in Focus

��ֳ� at ECTS 2022: Highlighting solutions to meet the needs of people living with osteoporosis